Enhanced tumor radiosensitivity by a survivin dominant-negative mutant. 2010

Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Sichuan, P.R. China.

Radiosensitivity of tumors is due to a complex interaction of various factors, it has been reported that survivin also acts as a constitutive and inducible radioresistance factor in a panel of tumor cells and approaches designed to inhibit survivin expression or function may lead to tumor sensitisation to chemical and physical agents. Previously, we found that the plasmid encoding the phosphorylation-defective mouse survivin threonine 34-->alanine mutant complexed to DOTAP-chol liposome (Lip-mS) can suppress murine primary breast carcinoma. However, little is known regarding the biological effect of Lip-mS combined with radiation. The present study was designed to determine whether Lip-mS could enhance the anti-tumor activity of radiation. The Lewis Lung Carcinoma (LLC) cells treated with a combination of Lip-mS and radiation displayed apparently increased apoptosis compared with those treated with Lip-mS or radiation alone. Mice bearing LLC tumors were treated with intravenous injections of Lip-mS and radiation, the combined treatment significantly reduced mean tumor volume compared with either treatment alone. Moreover, the anti-tumor effect of Lip-mS combined with radiation was greater than their additive effect when compared with the expected effect of the combined treatment. These data suggest that inhibition of survivin using a dominant-negative mutant, survivin T34A, could sensitize LLC cells to radiation efficiently and the synergistic anti-tumor activity may in part result from increasing the apoptosis of tumor cells, inhibiting tumor angiogenesis and inducing a tumor-protective immune response in the combined treatment.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008869 Microtubule-Associated Proteins High molecular weight proteins found in the MICROTUBULES of the cytoskeletal system. Under certain conditions they are required for TUBULIN assembly into the microtubules and stabilize the assembled microtubules. Ensconsin,Epithelial MAP, 115 kDa,Epithelial Microtubule-Associate Protein, 115 kDa,MAP4,Microtubule Associated Protein,Microtubule Associated Protein 4,Microtubule Associated Protein 7,Microtubule-Associated Protein,Microtubule-Associated Protein 7,E-MAP-115,MAP1 Microtubule-Associated Protein,MAP2 Microtubule-Associated Protein,MAP3 Microtubule-Associated Protein,Microtubule Associated Proteins,Microtubule-Associated Protein 1,Microtubule-Associated Protein 2,Microtubule-Associated Protein 3,7, Microtubule-Associated Protein,Associated Protein, Microtubule,E MAP 115,Epithelial Microtubule Associate Protein, 115 kDa,MAP1 Microtubule Associated Protein,MAP2 Microtubule Associated Protein,MAP3 Microtubule Associated Protein,Microtubule Associated Protein 1,Microtubule Associated Protein 2,Microtubule Associated Protein 3,Microtubule-Associated Protein, MAP1,Microtubule-Associated Protein, MAP2,Microtubule-Associated Protein, MAP3,Protein 7, Microtubule-Associated,Protein, Microtubule Associated,Protein, Microtubule-Associated
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids

Related Publications

Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
October 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
September 2019, Cell death & disease,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
January 2007, Medical hypotheses,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
February 2002, Biochemical and biophysical research communications,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
August 2006, Cancer gene therapy,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
May 1998, Molecular carcinogenesis,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
November 1994, Gene therapy,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
January 1995, Cellular & molecular biology research,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
February 2008, Journal of leukocyte biology,
Qing-Zhong Yuan, and Chun-Ting Wang, and Yong-Qiu Mao, and Peng Zhang, and Hua-Shan Shi, and Zhi-Yong Li, and Li Pan, and Dan-Dan Yu, and Fei Leng, and Xiang Chen, and Wei Ying, and Jing-Hui Xu, and Wei Li, and Fan Wu, and Yuan Wen, and Tian-Tai Ma, and Yu-Quan Wei
December 2003, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!